You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

denosumab

Pronunciation: den-OH-sue-mab
Other Name(s): Xgeva®; Wyost™
Appearance: clear, colourless to slightly yellowish solution

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Patient Info Sheet

Oct 2024

What it is used for

Denosumab may:

  • Help relieve bone pain and prevent broken bones in some types of cancer that arise from or spread to the bones
  • Be used to treat giant cell tumour of bone in some patients
  • Be used to remove excess calcium in the blood that is a problem with some types of cancer, if other treatments have not worked
     

Denosumab is available as a biosimilar medication. See our biosimilar pamphlet for more information. 



You might also be interested in